Long-term lamivudine for chronic hepatitis B and cirrhosis: A real-life cohort study

doi:10.3748/wjg.v21.i46.13087

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 46

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7889)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

689

WORD

297

HTML

3321

Figures (1-5)

217

Tables (1-2)

235

Sum=4759

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1245

Download

1885

Sum=3130

Dec 14, 2015 (publication date) through Oct 6, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Dec 14, 2015; 21(46): 13087-13094
Published online Dec 14, 2015. doi: 10.3748/wjg.v21.i46.13087

Full Size Figure Download Figure

Figure 3 Incidence of liver cirrhosis in patients with chronic hepatitis B. LAM: Lamivudine; CHB: Chronic hepatitis B.

Citation: Su MH, Lu AL, Li SH, Zhong SH, Wang BJ, Wu XL, Mo YY, Liang P, Liu ZH, Xie R, He LX, Fu WD, Jiang JN. Long-term lamivudine for chronic hepatitis B and cirrhosis: A real-life cohort study. World J Gastroenterol 2015; 21(46): 13087-13094
URL: https://www.wjgnet.com/1007-9327/full/v21/i46/13087.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i46.13087